Search Results 741-750 of 16067 for SC

  1. CA 125 test - Mayo Clinic

    Learn how doctors use this blood test to measure levels of a tumor marker associated with ovarian cancer, fallopian tube cancer and other types of cancer.

  2. Publications - Lauren E. Tagliero, M.D. - Mayo Clinic

    ... SC, Elder BD, Sebastian AS. Titanium Cervical Cage Subsidence: Postoperative Computed Tomography Analysis Defining Incidence and Associated Risk Factors ...

  3. A Study to Evaluate ORIN1001 in Idiopathic Pulmonary Fibrosis Subjects - Mayo Clinic

    dabigatran, hirudin, direct factor Xa inhibitors) or high dose anti-platelet therapy. Aspirin <81 mg/day, prophylactic subcutaneous (SC) heparin or SC low- ...

  4. David C. Fipps, D.O. - Doctors and Medical Staff - Mayo Clinic

    University of South Carolina. 2016. Doctor of Osteopathic MedicineLake Erie College of Osteopathic Medicine. 2011. BS - Biology and Minor in Chemistry. Summa ...

  5. Inclisiran (subcutaneous route) - Side effects & uses - Mayo Clinic

    Inclisiran injection is used together with a proper diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in patients with ...

  6. Select a county IA, Catchment County, Winnebago. Winnebago County Population Total: 10,354. Catchment County. Catchment County (MCHS). Selected County.

  7. Data Sources: Incidence and Mortality from State Cancer Profiles (for FL, AZ, WI, IA. MN data from MN Dept. of Health), Risk Factors & Screening from CDC, ...

  8. Mayo Clinic in Florida offers rare procedure for cancer patients: Photodynamic stabilization of skeletal metastatic disease

    Metastases break through bones, requiring rapid treatment for patients who are ineligible for total joint arthroplasty. Mayo Clinic offers photodynamic ...

  9. Publications - Carlos B. Mantilla, M.D., Ph.D. - Mayo Clinic

    Laporta ML, Kruthiventi SC, Mantilla CB, Johnson RL, Sprung J, Portner ER, Schroeder DR, Weingarten TN. Three Risk Stratification Tools and Postoperative ...

  10. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    Has received subcutaneously (SC) golimumab, adalimumab, or certolizumab pegol within 6 weeks of the first study agent administration; Has received etanercept ...